ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.

NCT00461266 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Slow recruitment

Conditions

HIV Infections

Interventions

DRUG: enfuvirtide [Fuzeon]
DRUG: Antiretroviral therapy

Sponsor

Hoffmann-La Roche